Follow The Filings

VEEV Veeva Systems

Health Care, filed as VEEVA SYS INC (CL A COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 4 managers in 2026 Q2, sold by 1

  • 1 Owner
  • #217
  • Max 0.9%
  • Master 0.02%
  • $6.7M
  • 1 reduce

In 2026 Q3 Torray Investment Partners trimmed Veeva Systems.

Who owns this now

Largest portfolio weights among holders, up to 0.9% (Torray Investment Partners). Not free-float ownership.

  1. Torray Investment Partners Reduce 0.89%

Who owns VEEV

Sorted by value, long equity only, as of 2026 Q3.

History
Torray Investment Partners 0.89% Reduce −4.5% 23,518 $6.7M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by VEEV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VEEV insider trades
  • None no insider bought on the open market
  • $1.5M sold by 2 insiders outside a trading plan
  • $15.3M sold by 3 insiders under 10b5-1 plans
  1. Jonathan Faddis SVP, Gen. Counsel, Secretary
    Planned sale
    $1.6M 5,198 shares at $299.72 56% of stake
    Traded Oct 14 Filed Oct 16
    ↗
  2. Daniel J Rizzo EVP, Sales, Consulting, & Svcs
    Sale
    $1.3M 4,841 shares at $276.51 39% of stake
    Traded Oct 2 Filed Oct 5
    ↗
  3. Thomas D. Schwenger Pres. & Chief Customer Officer
    Planned sale
    $265K 1,000 shares at $265.20 5.1% of stake
    Traded Sep 14 Filed Sep 16
    ↗
  4. Priscilla Hung Director
    Sale
    $196K 750 shares at $261.04 19% of stake
    Traded Sep 9 Filed Sep 11
    ↗
  5. Thomas D. Schwenger Pres. & Chief Customer Officer
    Planned sale
    $2.8M 10,000 shares at $281.33 34% of stake
    Traded Aug 27 Filed Aug 31
    ↗
  6. Thomas D. Schwenger Pres. & Chief Customer Officer
    Planned sale
    $9M 36,000 shares at $250.23 65% of stake
    Traded Aug 13 Filed Aug 17
    ↗
  7. Thomas D. Schwenger Pres. & Chief Customer Officer
    Planned sale
    $1M 5,000 shares at $200.00 20% of stake
    Traded Jul 16 Filed Jul 20
    ↗
  8. Priscilla Hung Director
    Planned sale
    $117K 750 shares at $155.64 19% of stake
    Traded Apr 30 Filed May 4
    ↗
  9. Priscilla Hung Director
    Planned sale
    $115K 750 shares at $153.50 16% of stake
    Traded Apr 10 Filed Apr 14
    ↗
  10. Thomas D. Schwenger Pres. & Chief Customer Officer
    Planned sale
    $200K 1,000 shares at $200.00 4.3% of stake
    Traded Mar 5 Filed Mar 9
    ↗
  11. Thomas D. Schwenger Pres. & Chief Customer Officer
    Planned sale
    $231K 1,000 shares at $231.43 4.1% of stake
    Traded Jan 13 Filed Jan 15
    ↗
  12. Eleni Nitsa Zuppas President & Chief of Staff
    Sale
    $1.8M 6,000 shares at $306.62 19% of stake
    Traded Oct 7, 2025 Filed Oct 9, 2025
    ↗
  13. Jonathan Faddis SVP, Gen. Counsel, Secretary
    Planned sale
    $215K 720 shares at $298.12 8.4% of stake
    Traded Oct 6, 2025 Filed Oct 8, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 58 option exercises, 23 share withholdings for taxes, 6 other transactions, and 2 gifts.

Congress

3 members of Congress traded VEEV in the last three years: 2 buys and 4 sales. 3 members listed it in 2025 annual reports.

All Congress trades
  1. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K May 29, 2025 filed Jun 23, 2025
  2. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K May 16, 2025 filed Jun 9, 2025
  3. Byron Donalds R-FL-19 Sell $1K–$15K Mar 20, 2025 filed Apr 14, 2025
  4. Byron Donalds R-FL-19Spouse Sell $1K–$15K Mar 20, 2025 filed Apr 14, 2025
  5. John James R-MI-10 Sell $1K–$15K Jul 16, 2024 filed Sep 2, 2024
  6. John James R-MI-10 Buy $1K–$15K Nov 10, 2023 filed Sep 2, 2024

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 11 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $2.16B $2.36B $2.75B $3.2B
Gross profit $1.55B $1.69B $2.05B $2.41B
Gross margin * 71.7% 71.3% 74.5% 75.5%
Net income $487.71M $525.7M $714.14M $908.91M
Net margin * 22.6% 22.2% 26.0% 28.4%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $3.97B $5B $6.31B $8B
Total non-current assets * $0.835B $0.908B $1.03B $0.982B
Total assets $4.8B $5.91B $7.34B $8.98B
Total current liabilities $1.01B $1.18B $1.4B $1.64B
Total non-current liabilities * $81.24M $87.21M $108.98M $127.54M
Total equity $3.72B $4.64B $5.83B $7.21B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $0.78B $0.911B $1.09B $1.42B
Cash from investing -$1.01B -$1.08B -$0.7B -$1.1B
Cash from financing -$19.38M -$16.19M $26.12M -$9.33M
Net change in cash -$251.58M -$182.98M $414.29M $302.45M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.